Innovation at Penn
Browse Penn-owned technologies available for licensing.
Search Results - david+christianson
New designs of arginase inhibitors as therapeutic and diagnostic agents
Technology Overview: Researchers in the Christianson Lab have designed arginase inhibitors that bind to arginase I and II, and conducted structural analyses of several three-dimensional crystal structures with arginase-inhibitor complexes. Inhibiting arginase enhances nitric oxide-dependent smooth muscle relaxation, including gastrointestinal, airway,...
Therapeutics & Vaccines
Chemical Processes and Synthesis
© 2021. All Rights Reserved. Powered by